MUC16 (−)/(+) patients with CCA did not differ in any other clinicopathological findings including common risk factors such as viral hepatitis, primary sclerosing cholangitis, liver cirrhosis, or cholelithiasis. This evidence concerns the gene MUC16 and cirrhosis of liver.